Canada Markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
157.50+8.40 (+5.63%)
At close: 04:00PM EDT
156.55 -0.95 (-0.60%)
After hours: 07:56PM EDT
Full screen
Loading interactive chart...
  • Zacks

    FDA Recommends Adding New Omicron Subvariants to COVID Boosters

    In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subvariants.

  • Yahoo Finance

    Omicron: Experts want more data to guide US targeting of fall boosters

    The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.

  • Motley Fool

    Why BioNTech Stock Advanced Today

    Shares of the German coronavirus vaccine developer BioNTech (NASDAQ: BNTX) have climbed by more than 5.6% as of 12:07 p.m. ET on Thursday due to news released Wednesday evening that the U.S. government had signed a new supply agreement for 105 million doses of its Comirnaty jab. The company and its collaborator, Pfizer (NYSE: PFE), will be paid $3.2 billion when the government receives the doses it ordered, and the deal also includes the option to purchase another 195 million doses if needed. The supply agreement also implies a price per dose that's 27% higher than what was negotiated in prior agreements.